Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation

Camille Martin-Gallausiaux,Laurène Salesse,Diego Garcia-Weber,Ludovica Marinelli,Fabienne Beguet-Crespel,Vincent Brochard,Camille Le Gléau,Alexandre Jamet,Joël Doré,Hervé M. Blottière,Cécile Arrieumerlou,Nicolas Lapaque
DOI: https://doi.org/10.1080/19490976.2023.2295384
IF: 12.2
2023-12-23
Gut Microbes
Abstract:The anaerobic bacterium Fusobacterium nucleatum is significantly associated with human colorectal cancer (CRC) and is considered a significant contributor to the disease. The mechanisms underlying the promotion of intestinal tumor formation by F. nucleatum have only been partially uncovered. Here, we showed that F. nucleatum releases a metabolite into the microenvironment that strongly activates NF-κB in intestinal epithelial cells via the ALPK1/TIFA/TRAF6 pathway. Furthermore, we showed that the released molecule had the biological characteristics of ADP-heptose. We observed that F. nucleatum induction of this pathway increased the expression of the inflammatory cytokine IL-8 and two anti-apoptotic genes known to be implicated in CRC, BIRC3 and TNFAIP3 . Finally, it promoted the survival of CRC cells and reduced 5-fluorouracil chemosensitivity in vitro . Taken together, our results emphasize the importance of the ALPK1/TIFA pathway in Fusobacterium induced-CRC pathogenesis, and identify the role of ADP-H in this process.
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?